Equities research analysts expect Nu Skin Enterprises, Inc. (NYSE:NUS) to report $0.93 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Nu Skin Enterprises’ earnings, with estimates ranging from $0.92 to $0.95. Nu Skin Enterprises posted earnings of $1.08 per share in the same quarter last year, which would suggest a negative year over year growth rate of 13.9%. The firm is expected to announce its next earnings report on Thursday, August 1st.
According to Zacks, analysts expect that Nu Skin Enterprises will report full year earnings of $3.92 per share for the current fiscal year, with EPS estimates ranging from $3.85 to $4.00. For the next financial year, analysts anticipate that the firm will report earnings of $4.30 per share, with EPS estimates ranging from $4.20 to $4.53. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that cover Nu Skin Enterprises.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.77 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.71 by $0.06. Nu Skin Enterprises had a net margin of 4.82% and a return on equity of 26.81%. The business had revenue of $623.60 million for the quarter, compared to analyst estimates of $615.98 million. During the same quarter in the previous year, the business earned $0.79 earnings per share. The firm’s revenue was up 1.2% compared to the same quarter last year.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Mackay Shields LLC grew its position in Nu Skin Enterprises by 79.0% during the fourth quarter. Mackay Shields LLC now owns 79,714 shares of the company’s stock valued at $4,889,000 after purchasing an additional 35,188 shares in the last quarter. Delek Group Ltd. purchased a new position in Nu Skin Enterprises during the first quarter valued at approximately $17,859,000. Amalgamated Bank grew its position in Nu Skin Enterprises by 14.8% during the fourth quarter. Amalgamated Bank now owns 11,484 shares of the company’s stock valued at $704,000 after purchasing an additional 1,483 shares in the last quarter. MERIAN GLOBAL INVESTORS UK Ltd grew its position in Nu Skin Enterprises by 8.9% during the fourth quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 813,238 shares of the company’s stock valued at $49,875,000 after purchasing an additional 66,408 shares in the last quarter. Finally, Squarepoint Ops LLC grew its position in Nu Skin Enterprises by 55.4% during the fourth quarter. Squarepoint Ops LLC now owns 109,000 shares of the company’s stock valued at $6,685,000 after purchasing an additional 38,844 shares in the last quarter. 77.17% of the stock is currently owned by hedge funds and other institutional investors.
NUS stock opened at $48.04 on Tuesday. Nu Skin Enterprises has a 52-week low of $44.36 and a 52-week high of $88.68. The company has a current ratio of 1.86, a quick ratio of 1.10 and a debt-to-equity ratio of 0.44. The company has a market cap of $2.80 billion, a PE ratio of 13.65, a PEG ratio of 1.16 and a beta of 0.73.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Friday, May 31st were given a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a yield of 3.08%. The ex-dividend date of this dividend was Thursday, May 30th. Nu Skin Enterprises’s payout ratio is presently 42.05%.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.